Information on audit
Information on audited Financial statements for the nine month period as at 30th of September of 2024
December 23, 2024 01:30 ET | Urbo Bankas
Urbo bankas UAB (hereinafter - “the Bank”), company code 112027077, address: Konstitucijos pr.18B, Vilnius. The Bank earned a net profit of EUR 6.5 million in the first three quarters of this year....
Basilea-Logo.jpg
Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics
December 23, 2024 01:15 ET | Basilea Pharmaceutica AG, Allschwil
Additional funding awarded following successful drug candidate nominationUSD 7.3 million to support progression of antibiotic BAL2420 (LptA inhibitor) towards first-in-human clinical studies Ad hoc...
sequana_rgb_300.png
Press release: Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis
December 23, 2024 01:00 ET | Sequana Medical NV
Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis alfapump® is the first US approved active implantable medical device...
Start of Day Message
December 23, 2024 01:00 ET | GlobeNewswire, Inc.
LONDON, 23 Dec. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Sanofi new_logo.jpg
Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines
December 23, 2024 01:00 ET | Sanofi - Aventis Groupe
Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Pneumococcal disease remains a major global health...
fagron-logo.png
Fagron updates on FDA communication regarding the June 2024 inspection at Wichita
December 23, 2024 01:00 ET | Fagron NV
Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 23 Dec 2024 – 7AM CET Fagron updates on FDA communication regarding the June 2024 inspection at Wichita ...
Grigeo Group_RGB.png
Information release calendar for 2025
December 23, 2024 00:00 ET | Grigeo Group AB
Interim information of Grigeo Group AB will be prepared and financial results will be released on these dates: February 25, 2025 – Interim Financial Statements for 12 months of 2024.April 8,...
July 30, 2021 - ROSEN LOGO.jpg
Western Asset Mutual Fund Investors That Suffered Losses Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation into the Company – LAOIX, WATFX, WACPX
December 22, 2024 23:10 ET | The Rosen Law Firm PA
NEW YORK, Dec. 22, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of Western Asset Management...
July 30, 2021 - ROSEN LOGO.jpg
Unisys Corporation Announcement: If You Have Suffered Losses in Unisys Corporation (NYSE: UIS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
December 22, 2024 23:02 ET | The Rosen Law Firm PA
NEW YORK, Dec. 22, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Unisys...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
December 22, 2024 22:59 ET | The Rosen Law Firm PA
NEW YORK, Dec. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Applied Therapeutics,...